Legend Biotech (LEGN) Net Margin (2019 - 2025)
Legend Biotech (LEGN) reported Net Margin of 0.82% for Q4 2025, up 3245.0% on a YoY basis from 0.02% in Q4 2024, and up 105.78% quarter-over-quarter from 14.12% in Q3 2025.
Legend Biotech (LEGN) Net Margin (2019 - 2025) Analysis & Trends
Legend Biotech has reported Net Margin for 7 years, with the latest figure at 0.82% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 3245.0% year-over-year to 0.82%; the trailing twelve-month figure through Dec 2025 stood at 25.38% (up 4529.0% YoY), and the FY2025 full-year result was 3.22%, up 3331.0% from the prior year.
- Net Margin for Q4 2025 stood at 0.82%, up from 14.12% in the prior quarter.
- The five-year high for Net Margin was 0.82% in Q4 2025, with the low at 1614.13% in Q2 2022.
- Historically, Net Margin has averaged 246.93% across 5 years, with a median of 71.51% in 2023.
- Annual changes were most pronounced in 2022 — Net Margin tumbled 116149 bps — and 2023, when it surged 134258 bps.
- Legend Biotech's Net Margin stood at 226.53% in 2021, then tumbled by 117 bps to 491.72% in 2022, then jumped by 100 bps to 0.11% in 2023, then sank by 28291 bps to 31.64% in 2024, then surged by 103 bps to 0.82% in 2025.
- The last three Net Margin figures came in at 0.82% (Q4 2025), 14.12% (Q3 2025), and 48.7% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 20.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.82% |
| Sep 30, 2025 | -14.12% |
| Jun 30, 2025 | -48.70% |
| Mar 31, 2025 | -51.74% |
| Dec 31, 2024 | -31.64% |
| Sep 30, 2024 | -78.23% |
| Jun 30, 2024 | -106.76% |
| Mar 31, 2024 | -63.62% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -64.79% |
| Jun 30, 2023 | -271.55% |
| Mar 31, 2023 | -308.51% |
| Dec 31, 2022 | -491.72% |
| Sep 30, 2022 | -310.50% |
| Jun 30, 2022 | -1,614.13% |
| Mar 31, 2022 | -64.53% |
| Dec 31, 2021 | -226.53% |
| Sep 30, 2021 | -738.96% |
| Jun 30, 2021 | -452.65% |
| Mar 31, 2021 | -0.66% |